BOULDER, Colo., Nov. 8, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Operating Officer, Andy Robbins, will present at the 2017 Stifel Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: |
Stifel Healthcare Conference |
Presenter: |
Andy Robbins, Chief Operating Officer |
Date: |
Wednesday, November 15, 2017 |
Time: |
11:00 a.m. Eastern Time |
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).
CONTACT: |
Tricia Haugeto |
Array BioPharma Inc. |
|
303-386-1193 |
|
SOURCE Array BioPharma
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article